Do NHS Trusts Reimburse Cannabis Prescriptions for Mood Disorders? 

The issue of NHS cannabis coverage is particularly important for patients with mood disorders . While medical cannabis is legal in the UK, prescriptions are extremely rare on the NHS, especially for a mental health condition  such as depression or bipolar disorder. For most patients, the question becomes whether NHS trusts will cover or reimburse cannabis prescriptions, or if private routes remain the only realistic option. 

The current situation reflects both financial considerations and gaps in clinical evidence. 

NHS Approach to Cannabis Prescriptions 

Looking at NHS cannabis coverage, it is clear that reimbursement policies are restrictive. Below are the main factors shaping access within NHS care. 

NHS Reimbursement of Cannabis 

At present, NHS reimbursement of cannabis is virtually non-existent for psychiatric conditions. Mood-related cases are often redirected to conventional treatments first. 

NHS Policy On Medical Cannabis 

The NHS policy on medical cannabis focuses on a small number of approved conditions, leaving mood disorders outside standard eligibility frameworks. 

Cannabis Depression And NHS 

The reality of cannabis, depression, and NHS services is that patients rarely receive cannabis through public pathways, instead turning to private clinics for prescriptions. 

In summary, NHS cannabis coverage does not extend to most patients with mood disorders, meaning private access remains the primary route. 

For those evaluating options, providers like LeafEase can help patients understand the differences between NHS policies and private treatment pathways. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders.